Radiosurgical options in neuro-oncology: a review on current tenets and future opportunities. Part II: adjuvant radiobiological tools

被引：40

作者：

Ganau, Mario ^{[1
,2
]}

Foroni, Roberto Israel ^{[1
]}

Gerosa, Massimo ^{[1
]}

Ricciardi, Giuseppe Kenneth ^{[3
]}

Longhi, Michele ^{[1
]}

Nicolato, Antonio ^{[1
]}

机构：

[1] AOUI, Univ Hosp, Dept Neurosci, Verona, Italy

[2] Univ Cagliari, Dept Biomed Engn, Cagliari, Italy

[3] AOUI, Univ Hosp, Dept Pathol & Diag, Verona, Italy

来源：

TUMORI JOURNAL | 2015年 / 101卷 / 01期

关键词：

Stereotactic radiosurgery; 3D-imaging; Radioenhancers; Radioprotective agents; BRAIN RADIATION-THERAPY; STEREOTACTIC RADIOSURGERY; GENE-EXPRESSION; PHASE-III; TUMOR RECURRENCE; SINGLE FRACTION; RADIOTHERAPY; IRRADIATION; METASTASES; INHIBITORS;

D O I：

10.5301/tj.5000215

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Stereotactic radiosurgery (SRS) is currently a well-established, minimally invasive treatment for many primary and secondary tumors, especially deep-sited lesions for which traditional neurosurgical procedures were poorly satisfactory or not effective at all. The initial evolution of SRS was cautious, relying on more than 30 years of experimental and clinical work that preceded its introduction into the worldwide medical community. This path enabled a brilliant present, and the continuous pace of technological advancement holds promise for a brighter future. Part II of this review article will cover the impact of multimodal adjuvant technologies on SRS, and their input to the crucial role played by neurosurgeons, radiation oncologists and medical physicists in the management and care of fragile neuro-oncological patients.

引用

页码：57 / 63

页数：7

共 49 条

[1] Optimizing Contrast-Enhanced Magnetic Resonance Imaging Characterization of Brain Metastases: Relevance to Stereotactic Radiosurgery [J].

Anzalone, Nicoletta ;

Essig, Marco ;

Lee, Seung-Koo ;

Doerfler, Arnd ;

Ganslandt, Oliver ;

Combs, Stephanie E. ;

Picozzi, Piero .

NEUROSURGERY, 2013, 72 (05) :691-701

[2]

Brown PD, 2008, NEUROSURGERY, V62, P790, DOI [10.1227/01.neu.0000316283.45242.e1, 10.1227/01.NEU.0000023713.44940.20]

[3] A perivascular niche for brain tumor stem cells [J].

Calabrese, Christopher ;

Poppleton, Helen ;

Kocak, Mehmet ;

Hogg, Twala L. ;

Fuller, Christine ;

Hamner, Blair ;

Oh, Eun Young ;

Gaber, M. Waleed ;

Finklestein, David ;

Allen, Meredith ;

Frank, Adrian ;

Bayazitov, Ildar T. ;

Zakharenko, Stanislav S. ;

Gajjar, Amar ;

Davidoff, Andrew ;

Gilbertson, Richard J. .

CANCER CELL, 2007, 11 (01) :69-82

[4]

Ceresoli GL, 2012, CURR CANCER DRUG TAR, V12, P237

[5]

Chang J.E., 2007, Clin. Adv. Hematol. Oncol, V5, P907

[6]

Chang Julie E, 2007, Clin Adv Hematol Oncol, V5, P894

[7]

Chiang CS, 1997, CANCER RES, V57, P3899

[8] Protecting venous structures during radiosurgery for parasagittal meningiomas [J].

Conti, Alfredo ;

Pontoriero, Antonio ;

Salamone, Ignazio ;

Siragusa, Carmelo ;

Midili, Federica ;

La Torre, Domenico ;

Calisto, Amedeo ;

Granata, Francesca ;

Romanelli, Pantaleo ;

De Renzis, Costantino ;

Tomasello, Francesco .

NEUROSURGICAL FOCUS, 2009, 27 (05) :E11.1-E11.5

[9]

Daigle JL, 2001, CANCER RES, V61, P8859

[10] Bevacizumab for refractory adverse radiation effects after stereotactic radiosurgery [J].

Deibert, Christopher P. ;

Ahluwalia, Manmeet S. ;

Sheehan, Jason P. ;

Link, Michael J. ;

Hasegawa, Toshinori ;

Yomo, Shoji ;

Feng, Wu Han ;

Li, Pan ;

Flickinger, John C. ;

Lunsford, L. Dade ;

Kondziolka, Douglas .

JOURNAL OF NEURO-ONCOLOGY, 2013, 115 (02) :217-223

← 1 2 3 4 5 →